Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice

Keiko Takahashi(Vanderbilt University Medical Center), Takamune Takahashi(Vanderbilt University Medical Center)
American Journal of Physiology-Renal Physiology
January 27, 2020
10.1152/ajprenal.00288.2019
Cited by 8

Related Papers

Determination of the CD148-Interacting Region in Thrombospondin-1
|PLoS ONE|2016|19
Clinical and experimental approaches for imaging of acute kidney injury
|Clinical and Experimental Nephrology|2021|15
The effects of <scp>CD148 Q276P</scp>/<scp>R326Q</scp> polymorphisms in <scp>A431D</scp> epidermoid cancer cell proliferation and epidermal growth factor receptor signaling
|Cancer Reports|2021|5
Protein Tyrosine Phosphatase 1B (PTP1B) Deficiency Substantially Attenuates Glomerular Injury in Endothelial Nitric Oxide Synthase (eNOS)-Deficient Diabetic Mice
|Cureus|2025|0